X0202 SCHEDULE 13G/A 0001104659-25-009441 0001325083 XXXXXXXX LIVE 1 Common Stock, par value $0.01 per share 07/01/2026 0001601485 Elicio Therapeutics, Inc 28657F103 451 D Street, 5th Floor Boston MA 02210 Rule 13d-1(c) Knoll Capital Management, LLC b FL 0.00 1211957.00 0.00 1211957.00 1211957.00 N 5.3 OO LLC Fred Knoll b X1 0.00 1211957.00 0.00 1211957.00 1211957.00 N 5.3 IN Gakasa Holdings, LLC b X1 0.00 1211957.00 0.00 1211957.00 1211957.00 N 5.3 OO Gakasa Holdings, LLC beneficially owns 1,211,957 shares of the Issuer's Common Stock. Knoll Capital Management has trading authority for Gakasa, and Fred Knoll is the President of Knoll Capital Management, LLC. Elicio Therapeutics, Inc 451 D Street, 5th Floor Boston, MA, 02210 Knoll Capital Management, LLC. Fred Knoll. Gakasa Holdings LLC. 201 S. Biscayne Blvd suite 800, Miami, FL 33131 USA Y 1,211,957 5.3% 0 1,211,957 0 1,211,957 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Knoll Capital Management, LLC Fred Knoll 07/07/2026 Fred Knoll Fred Knoll 07/07/2026 Gakasa Holdings, LLC Fred Knoll 07/07/2026